Oak Street Health, Inc. (NYSE:OSH) Insider Robert Guenthner Sells 8,250 Shares

Oak Street Health, Inc. (NYSE:OSH – Get Rating) insider Robert Guenthner sold 8,250 shares of the stock in a transaction that occurred on Thursday, March 9th. The shares were sold at an average price of $35.43, for a total value of $292,297.50. Following the sale, the insider now directly owns 432,759 shares of the company’s stock, valued at $15,332,651.37. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Robert Guenthner also recently made the following trade(s):

• On Thursday, February 2nd, Robert Guenthner sold 592 shares of Oak Street Health stock. The shares were sold at an average price of $28.85, for a total value of $17,079.20.
• On Thursday, January 26th, Robert Guenthner sold 8,250 shares of Oak Street Health stock. The shares were sold at an average price of $28.36, for a total value of $233,970.00.

Oak Street Health Stock Performance

Shares of NYSE OSH opened at $35.24 on Wednesday. The stock has a market cap of $8.60 billion, a PE ratio of -15.95 and a beta of 2.22. Oak Street Health, Inc. has a fifty-two week low of $13.29 and a fifty-two week high of $35.65. The stock has a fifty day moving average of $31.48 and a 200-day moving average of $25.61.

Oak Street Health (NYSE:OSH – Get Rating) last announced its quarterly earnings results on Tuesday, February 28th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. The company had revenue of $577.70 million during the quarter, compared to analysts’ expectations of $571.26 million. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 23.57%. The firm’s quarterly revenue was up 46.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.62) earnings per share. On average, sell-side analysts predict that Oak Street Health, Inc. will post -1.58 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently commented on the company. Piper Sandler downgraded Oak Street Health from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $47.00 to $39.00 in a research report on Wednesday, February 8th. Stifel Nicolaus downgraded Oak Street Health from a “buy” rating to a “hold” rating in a research report on Wednesday, February 8th. Sanford C. Bernstein downgraded Oak Street Health from an “outperform” rating to a “market perform” rating and raised their target price for the stock from $35.00 to $39.00 in a research report on Wednesday, February 15th. JPMorgan Chase & Co. downgraded Oak Street Health from an “overweight” rating to a “neutral” rating and raised their target price for the stock from $35.00 to $39.00 in a research report on Thursday, February 23rd. Finally, Raymond James downgraded Oak Street Health from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 9th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $32.67.

Institutional Investors Weigh In On Oak Street Health

Several large investors have recently added to or reduced their stakes in the business. Point72 Middle East FZE bought a new stake in Oak Street Health during the fourth quarter valued at $381,000. State of Wyoming bought a new stake in Oak Street Health during the fourth quarter valued at $99,000. Public Employees Retirement System of Ohio boosted its stake in Oak Street Health by 2.1% during the fourth quarter. Public Employees Retirement System of Ohio now owns 59,713 shares of the company’s stock valued at $1,284,000 after buying an additional 1,253 shares during the period. Captrust Financial Advisors bought a new stake in Oak Street Health during the fourth quarter valued at $215,000. Finally, Susquehanna Fundamental Investments LLC bought a new stake in Oak Street Health during the fourth quarter valued at $5,562,000. Institutional investors own 92.04% of the company’s stock.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.